IV Tamiflu first drug to receive EMA approval for compassionate use

The Pharmaceutical Journal Group

首页> 外文期刊>The pharmaceutical journal >IV Tamiflu first drug to receive EMA approval for compassionate use

【24h】

IV Tamiflu first drug to receive EMA approval for compassionate use

机译：IV达菲（Tamiflu）第一种获得EMA批准用于同情使用的药物

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Intravenous Tamiflu (oseltamivir; Roche) has become the first treatment to be recommended on compassionate use grounds by the European Medicines Agency.

机译：静脉注射达菲（oseltamivir; Roche）已成为欧洲药品管理局出于同情使用理由而推荐的第一种治疗方法。

著录项

来源
《The pharmaceutical journal》 |2010年第7587期|共1页
作者
The Pharmaceutical Journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. IV Tamiflu first drug to receive EMA approval for compassionate use [J] . The Pharmaceutical Journal Group The pharmaceutical journal . 2010,第7587期

机译：IV达菲（Tamiflu）第一种获得EMA批准用于同情使用的药物
2. Comparison of Drug Approvals in Europe Versus the United States: An Analysis of Discrepancies Between Drug Products Reviewed by EMA and FDA [J] . Robert W. Makuch, Ruizhi Shi Drug information journal . 2014,第3期

机译：欧洲与美国的药品批准比较：EMA和FDA审查的药品之间的差异分析
3. Comparison of Drug Approvals in Europe Versus the United States: An Analysis of Discrepancies Between Drug Products Reviewed by EMA and FDA [J] . Makuch Robert W., Shi Ruizhi Therapeutic innovation & regulatory science. . 2014,第3期

机译：欧洲与美国的药品批准比较：EMA和FDA审查的药品之间的差异分析
4. Investigating the Food and Drug Administration (FDA) Biotherapeutics Review and Approval Process: A Scoping Review [C] . Samuel A. Bonet, Farzan Sasangohar, Mark Lawley Human Factors and Ergonomics Society annual meeting . 2018

机译：调查食品和药物管理局（FDA）生物治疗审查和审批过程：审查审查
5. Meta-Analysis to Identify and Evaluate Factors Associated with Regulatory Approval of Orphan Drugs (OD) to Develop an Algorithm for Predicting Regulatory Approval (Success) and to Develop a Standardized Tool to Improve Orphan Drug Portfolio Decision-Making [D] . Florent, Milky C. 2019

机译：荟萃分析，以识别和评估与孤儿药物监管批准（OD）相关的因素，以开发预测监管批准（成功）的算法，并开发标准化工具以改善孤儿药物投资组合决策
6. FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis [O] . Chandra P. Leo, Bettina Hentschel, Thomas D. Szucs, 2020

机译：FDA和EMA批准了新的乳腺癌药物-比较法规分析
7. PHP22 Evaluating Criticism Of The Fda Accelerated Approval Pathway - Ema Evaluation Of Drugs That Have Been Withdrawn Following Accelerated Approval By The Fda [O] . Macaulay R. 2014

机译：PHP22评估对Fda加速批准途径的批评-Ema评估Fda加速批准后撤回的药物

IV Tamiflu first drug to receive EMA approval for compassionate use

摘要

著录项

相似文献

相关主题

期刊订阅